Prairie Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Hold
0
130
2025
Q4
Sell
-9,762
Closed -$246K 141
2025
Q3
$249K Sell
9,762
-417
-4% -$10.3K 0.1% 134
2025
Q2
$247K Buy
10,179
+107
+1% +$2.5K 0.11% 130
2025
Q1
$255K Buy
10,072
+665
+7% +$17.4K 0.13% 121
2024
Q4
$250K Buy
9,407
+1,791
+24% +$48.6K 0.12% 130
2024
Q3
$220K Buy
+7,616
New +$222K 0.11% 136

Other funds holding PFE

Prairie Wealth Advisors's PFE Position: Q1 2026 in Review

Prairie Wealth Advisors held its Pfizer (PFE) position steady in Q1 2026 at 0 shares worth $248K. The position accounts for 0.11% of the portfolio, ranked #130.

Prairie Wealth Advisors first reported a position in PFE in Q3 2024 and has held it in 5 quarters since. The position peaked at $255K in Q1 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Prairie Wealth Advisors held 0 shares of Pfizer worth $248K as of Q1 2026.
  • Prairie Wealth Advisors left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.11% of Prairie Wealth Advisors's portfolio in Q1 2026, its #130 holding.
  • Prairie Wealth Advisors first reported a position in Pfizer in Q3 2024 and has held it in 5 quarters since.
  • Prairie Wealth Advisors's Pfizer position peaked at $255K in Q1 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Prairie Wealth Advisors's 13F filing for Q1 2026, filed 5 May 2026.